Marina I. Miller, Ph.D., is an intellectual property (IP) partner in the firm’s Chemical Patent Prosecution group and has extensive experience in patent applications preparation and all aspects of U.S. and foreign patent prosecution in diversified technologies within the pharmaceutical, chemical, biotechnology, medical, physics and engineering disciplines including recombinant DNA technology, genetics, immunology, enzymology, medical diagnostics, microarrays and statistical data analysis, genomics and proteomics, bioinformatics, nanotechnology and plasmonics, phototherapy, polymer chemistry, imaging, medical devices, optical films and coatings, cosmetics, catalysts, ceramics, alloys, chemical engineering, optical and electronic devices, and battery materials including solid electrolytes, solid-state batteries, and anode and cathode materials for lithium-ion batteries. Her legal experience covers all aspects of client counseling, patent portfolio development and management, prosecution, post grant proceedings, appeals, opinions of counsel, due diligence, and pre-litigation counseling. She works actively with international and domestic clients to develop and grow their patent portfolios.
Dr. Miller has experience litigating pharmaceutical patents including abbreviated new drug application (ANDA) litigations, advising pioneering and generic pharmaceutical companies on U.S. Food and Drug Administration issues, and providing counseling and due diligence investigatory guidance. She has also evaluated IP issues that arise in corporate mergers and acquisitions and provided advice on building IP portfolios.
Prior to joining Oblon, Dr. Miller served as a Patent Examiner in the field of bioinformatics with the United States Patent and Trademark Office (USPTO). She also was a law clerk and scientific advisor in the IP litigation department of a leading national law firm, with an emphasis on client counseling and litigation in matters involving pharmaceutical compounds, formulations, polymorphs, genetically engineered crops, and polymers.
Her industry and academic experience includes working as a research scientist at the Center for Advanced Research in Biotechnology in Maryland, where she conducted structural studies of antigen recognition by T-cell receptors (TCRs) and T-cell activation by various superantigens. She was also a post-doctoral fellow at the Cornell Medical College at New York, where she researched the role of myosin-binding proteins in skeletal muscle and the heart. Dr. Miller is the author of 32 scientific publications and is named as an inventor on issued patents and patent applications worldwide.
Before attending law school, Dr. Miller received a Ph.D. in molecular biology/biochemistry from the All Union Research Institute of Genetics and Selection of Industrial Microorganisms in Moscow, Russia. Her thesis research focused on the discovery of a new approach for optimizing foreign gene expression in bacteria and expression and purification of different types of interleukins and chemokines. Dr. Miller also has a master’s degree in physics from the Moscow Physics-Engineering Institute.
Dr. Miller is fluent in Russian.
Selected Peer-Reviewed Publications: